Results

Total Results: 1,524 records

Showing results for "drugs".

1241. Hepatitis-C-Screening Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
      November 01, 2012 - injection drug users.16-22 About 60 percent of new infections occur in individuals who report injecting drugs … partners, unprotected sex, and/or sex with a person infected with HCV infection or using injection drugs … Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health

1242. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
      March 01, 2012 - For drugs like etidronate and sodium fluoride that could produce abnormal bone (osteomalacia) fracture … Based on a new RCT, we have added Teriparatide to the conclusion about drugs that effectively prevent … Yet these drugs are not included in the efficacy section. Delete. … These drugs have been omitted from the evidence table as they were deleted from the report. … A review of studies examining the characteristics of the drugs was beyond the scope of this project.

1243. uterine-fibroids-protocol-160301 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
      March 01, 2016 -  bleeding;;  In  vitro   fertilization;;  Precocious  puberty;;  Prostate  cancer   AstraZeneca   Pharmaceuticals … indications:     Endometrial  hyperplasia;;  Endometriosis;;   Menopausal  symptom   Bayer  Healthcare   Pharmaceuticals

1244. Data-Points-8 Tables1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
      January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypretensive Drugs

1245. Hypertension-Pulmonary-Arterial Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
      April 01, 2013 - These new data may clarify any effect on mortality and gauge the comparative effectiveness of these drugs … Additionally, combination drug therapy (using multiple drugs with different mechanisms of action) is … In order to 5 optimize PAH care, newer information regarding the latest drugs and combination therapies … compared a single drug (monotherapy) with placebo or standard therapy and included the following drugs … Drugs did not significantly differ in their odds of causing dizziness or diarrhea.

1246. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
      December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

1247. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1248. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1249. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
      December 04, 2015 - that is currently available in the United States; we will assess the evidence for all uses of these drugs … We will search for clinical study reports from the European Medicines Agency, and search Drugs@FDA for … We will revise the inclusion/exclusion form from the original review (e.g., add conditions and new drugs … However, such an approach does not allow for comparisons between drugs that may not have much direct … evidence (e.g., drug A has been compared to drug B and C, but drugs B and C have not been directly

1250. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
      November 02, 2018 - pharmacological interventions, and nonprescription pharmacological interventions (e.g., over-the-counter drugs … claims abound on the internet and elsewhere about the cognitive benefits of dozens of over-the-counter drugs … Prescription Drugs Used for Treatment of CATD Cognition, Function, Quality of Life or BPSD Class of … inhibitors, NMDA antagonists, KQ 4-6: For targeting BPSD and quality of life outcomes: Prescription drugs … Since this outcome eliminated, drugs targeted to these symptoms should be eliminated.

1251. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
      January 01, 2014 - Should drugs be administered right before PCI, 6 hours prior, 12 hours prior if possible? … I found the descriptions of the classes of drugs very helpful. … This is already a very large report, and delving further into the background for these drugs is out … UFH given the small number of studies with a head-to- head comparison of those drugs. … However, in KQ 1, all three drugs were compared.

1252. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations From the Effective Health Care Program (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
      January 01, 2013 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … PICO (Intervention): Corticosteroids; Synthetic disease- modifying anti- rheumatic drugs (DMARDs)

1253. CER 217 Management of Infertility Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
      May 01, 2019 - use of ovulation-induction agents including oral (clomiphene citrate or letrozole) and injected drugs … Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. … Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. … Effects of fertility drugs on cancers other than breast and gynecologic malignancies. … Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

1254. Microsoft Word - finbody.doc (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
      January 01, 2007 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … currently used interventions, including angioplasty with stent placement and/or those antihypertensive drugs … explicitly evaluated aggressive medical treatment with ACE inhibitors, statins, and anti-platelet drugs … after revascularization do occur in a small percentage of patients, and each of the antihypertensive drugs … eligibility criteria reported analyses of whether periprocedural interventions, such as different drugs

1255. Disposition of Comments Report for Evaluation and Treatment of Tinnitus (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_disposition-comments.pdf
      August 23, 2013 - Initially, these interventions were grouped together and labeled ‘medical’ because drugs and surgeries … I cannot see any advantage to lumping these drugs together but if you do want to group them, the only … We refer to gabapentin, baclofen, alprazolam, and acamprosate as neurotransmitter drugs and specify … Two of these feature experimental drugs that are not currently commercially available and this may be … Similarly, the grouping of antidepressants were in fact 4 different drugs with differing doses.

1256. Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
      October 01, 2017 - These reviews focus on a variety of issues, including assessing and comparing clinical drugs, treatments … I feel like the thing that I'm most struggling with from an evidence-based standpoint, is limiting pharmaceuticals … o What are the opportunities to substitute less costly, but equally effective, pharmaceuticals for specific … These reviews focus on a variety of issues, including comparing clinical drugs or treatments, and interventions … o Prevention strategies o Diagnostic strategies o Treatment strategies  Drugs, devices, non-pharmaceuticals

1257. Cad-Pci-Bypass Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
      May 01, 2013 - CER #9: Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease Original release date: October 2007 Surveillance Report: May 2013 Key Findings: - New RCT and cohort studies further delineate which patients have improved outcome…

1258. Stroke-Atrial-Fibrillation Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
      August 01, 2013 - , Bleeding history or predisposition, Labile international normalized ratio, Elderly [>65 years], Drugs … Despite all the potential advantages of the new drugs demonstrated in the clinical trials when compared … with warfarin, the new drugs still do not have a well-validated and -studied immediate antidote. … The shorter half-life of the novel drugs may help in the management of bleeding episodes in patients … receiving these drugs and should provide comfort that bleeding can be controlled without an antidote

1259. Disposition of Comments for CER 165 Fecal Incontinence (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
      March 21, 2016 - For example, the easiest treatments to study (drugs) are not necessarily those that are used most … With diet drugs being 'symptom' and replacing sphincter being 'cure' - the issue would be what does … Stool modifying drugs are listed as BOTH pharmacological treatments and standard care treatments. … We assume that the Reviewer is referring to diet, over the counter drugs, PFMT, education, toileting … offers any advantage over standard care (such as dietary fiber supplementation, stool- modifying drugs

1260. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
      January 01, 2010 - Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care program. It is a collaborative network of research centers that support the rapid development o…